Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum: Evaluation of Clinical Practices in Five Maternity Hospitals in Île-de-France

This clinical trial aims to evaluate the adequacy of healthcare professionals' clinical practices regarding nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG) with the recommendations of the National College of French Obstetricians and Gynecologists (CNGOF). The study involves 117 participants and follows an observational, cross-sectional, multicenter study design conducted in five maternity hospitals in Île-de-France.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

He Study Focuses on Evaluating Current Clinical Practices Rather Than Testing an Intervention Female Urogenital Diseases and Pregnancy Complications Hyperemesis Gravidarum Morning Sickness Pathological Conditions, Signs and Symptoms Pregnancy Complications Signs and Symptoms Signs and Symptoms, Digestive Urogenital Diseases Vomiting

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier de Saint-Denis

Saint-Denis, 93200, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Midwives, obstetrician-gynecologists, and gynecology-obstetrics interns working in the labor and delivery units, high-risk pregnancy units, and obstetric-gynecological emergency units of the five selected maternity hospitals.

Exclusion criteria

Midwives or doctors in training (student midwives or medical externs)
Midwives and obstetrician-gynecologists working in private practice

Treatment and study plan

Primary outcomes

Percentage of healthcare professionals whose management of NVP and HG aligns with CNGOF recommendations.

Time frame: data collection period: October 2023-March 2024

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Saint-Denis

Other

Registry information

Important dates

Study start: 2023
Primary completion: 2024
Study completion: 2024
First posted: Feb 21, 2025
Registry last updated: Feb 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed